tirzepatide corpus christi Compounded Semaglutide Weight Loss Clinic in

Weekly injections of semaglutide (2.4 mg) added to lifestyle changes resulted in clinically relevant weight loss for overweight or obese adults without diabetes

Document your current semaglutide dose, injection schedule, and any prior side effects so your healthcare provider can make informed decisions quickly if infection occurs

Some insurers demand a three-to-six-month waiting period after failed attempts with other treatments before approving semaglutide

Semaglutide (Wegovy, Ozempic) received FDA approval for chronic weight management in 2021, followed by tirzepatide (Zepbound) in 2023, both demonstrating substantial weight loss in clinical trials

however, they are still not approved for use and available in the market